X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (46) 46
life sciences (43) 43
index medicus (40) 40
female (36) 36
endocrinology & metabolism (33) 33
[ sdv ] life sciences [q-bio] (28) 28
male (28) 28
mesh : humans (25) 25
adult (24) 24
mesh : female (20) 20
middle aged (18) 18
aged (16) 16
mesh : male (15) 15
human health and pathology (13) 13
[sdv]life sciences [q-bio] (11) 11
internal medicine (11) 11
mesh : adult (10) 10
adolescent (9) 9
insulin (9) 9
young adult (9) 9
biochemistry (8) 8
diabetes (8) 8
medicine, general & internal (8) 8
risk (8) 8
risk factors (8) 8
abridged index medicus (7) 7
analysis (7) 7
beer (7) 7
chemistry (7) 7
compositions thereof (7) 7
culture media (7) 7
enzymology (7) 7
general tagging of cross-sectional technologies spanning over several sections of the ipc (7) 7
general tagging of new technological developments (7) 7
hypoglycemic agents (7) 7
mesh : aged (7) 7
metallurgy (7) 7
microbiology (7) 7
microorganisms or enzymes (7) 7
mutation or genetic engineering (7) 7
organic chemistry (7) 7
peptides (7) 7
pregnancy (7) 7
propagating, preserving or maintaining microorganisms (7) 7
spirits (7) 7
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (7) 7
technologies for adaptation to climate change (7) 7
technologies or applications for mitigation or adaptation againstclimate change (7) 7
therapy (7) 7
type 1 diabetes (7) 7
vinegar (7) 7
wine (7) 7
[ sdv.mhep ] life sciences [q-bio]/human health and pathology (6) 6
diabetes mellitus (6) 6
diabetes mellitus, type 2 (6) 6
diabetes mellitus, type 2 - drug therapy (6) 6
endocrinology and metabolism (6) 6
follow-up studies (6) 6
france (6) 6
glucose (6) 6
mesh : diabetes mellitus, type 2 (6) 6
mesh : hypoglycemic agents (6) 6
mesh : middle aged (6) 6
mesh : pregnancy (6) 6
mesh: humans (6) 6
mutation (6) 6
prevalence (6) 6
[sdv.mhep]life sciences [q-bio]/human health and pathology (5) 5
cardiovascular diseases (5) 5
cohort studies (5) 5
diagnosis (5) 5
double-blind method (5) 5
drug administration schedule (5) 5
epidemiology (5) 5
france - epidemiology (5) 5
glargine (5) 5
hypoglycemia (5) 5
hypoglycemic agents - therapeutic use (5) 5
management (5) 5
mesh : france (5) 5
mesh : risk factors (5) 5
mesh: female (5) 5
type 2 diabetes (5) 5
aged, 80 and over (4) 4
cancer (4) 4
care and treatment (4) 4
child (4) 4
children (4) 4
complications (4) 4
contraception (4) 4
diabetes mellitus, type 1 - drug therapy (4) 4
drug therapy, combination (4) 4
estrogens (4) 4
fertility (4) 4
glycemic control (4) 4
high prevalence (4) 4
impact (4) 4
insulin glargine (4) 4
insulin, long-acting (4) 4
insulin, long-acting - therapeutic use (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Genetics, ISSN 1061-4036, 2014, Volume 46, Issue 6, pp. 607 - 612
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 06/2015, Volume 100, Issue 6, pp. 2303 - 2313
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9825, pp. 1489 - 1497
Journal Article
Diabetes/Metabolism Research and Reviews, ISSN 1520-7552, 09/2018, Volume 34, Issue 6, pp. e3019 - n/a
Journal Article
Journal of Clinical Endocrinology and Metabolism, ISSN 0021-972X, 03/2017, Volume 102, Issue 3, pp. 923 - 932
Journal Article
by Gerstein, Hertzel C and Bosch, Jackie and Dagenais, Gilles R and Díaz, Rafael and Jung, Hyejung and Maggioni, Aldo P and Pogue, Janice and Probstfield, Jeffrey and Ramachandran, Ambady and Riddle, Matthew C and Rydén, Lars E and Yusuf, Salim and Richardson, L and Diaz, R and Johnston, P and Vige, R and Birkeland, K and Budaj, A and Cardona, E and Chazova, I and Commerford, P and Danilova, L and Davies, M and Fernando, R and Fodor, G and Gilbert, R and Gomis, R and Hâncu, N and Hanefeld, M and Hildebrandt, P and Kacerovsky-Bielesz, G and Keltai, M and Kim, J.H and Krum, H and Kültürsay, H and Lanas, F and Lewis, B.S and Lonn, E and López-Jaramillo, P and Marin-Neto, J and Marre, M and McKelvie, R and McQueen, M and Mendoza, I and Morillo, C and Pan, C and Pīrāgs, V and Profozic, V and Ratner, R and Richardson, L and Rosenstock, J and Spinas, G.A and Sreenan, S and Stoel, I and Syvänne, M and Yale, J.F and Avezum, A and Bahit, M.C and Bogaty, P and Bordeleau, L and Chacόn, C and Corson, M and Harper, W.L and Halon, D and Magloire, P and Mann, J and Pavlova, V and Punthakee, Z and Silva, J and Tsang, B and Yakubovich, N and Abdallah, A and Ahmad, S and Chandra, J and Chandra, R and Cukierman-Yaffee, T and Dyal, L and Joldersma, L and MacRae, L and MacRae, S and Malik, S and Mead, A and Pasha, F and Pazmino-Canizares, J and Pohl, K and Sakalas, A and Tyrwhitt, J and Ahuad Guerrero, R and Alebuena, A and Alvarez, N and Alzogaray, M and Amuchastegui, M and Andres, M and Angos, M and Baglivo, H and Barbieri, M and Bassi, F and Bello, F and Bono, J and Bustamante Labarta, M and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning, Västerås
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article